Ratings by BMO Capital (Joanne Wuensch)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/8/2026 | Zimmer Biomet | ZBH | New Coverage | Market Perform (N/A) |
89.41 (88.68) |
-0.82% | Details | |
| 9/3/2019 | DexCom | DXCM | Maintain | Outperform (N/A) |
|
Details | ||
| 8/22/2019 | Alcon Inc. | ALC | Maintain | Market Perform (Market Perform) |
|
Details | ||
| 8/21/2019 | Medtronic, Inc. | MDT | Maintain | Outperform (N/A) |
|
Details | ||
| 8/9/2019 | NuVasive | NUVA | Maintain | Market Perform (N/A) |
|
Details | ||
| 8/8/2019 | Wright Medical | WMGI | Maintain | Outperform (N/A) |
|
Details | ||
| 8/6/2019 | Insulet Corporation | PODD | Maintain | Outperform (N/A) |
|
Details | ||
| 8/2/2019 | Tandem Diabetes Care | TNDM | Maintain | Outperform (N/A) |
|
Details | ||
| 8/1/2019 | DexCom | DXCM | Maintain | Outperform (N/A) |
|
Details | ||
| 7/29/2019 | Zimmer Biomet | ZBH | Maintain | Outperform (N/A) |
|
Details | ||
| 7/26/2019 | Stryker | SYK | Maintain | Market Perform (N/A) |
|
Details | ||
| 7/26/2019 | Baxter International | BAX | Maintain | Outperform (N/A) |
|
Details | ||
| 7/24/2019 | Edwards Lifesciences | EW | Maintain | Outperform (N/A) |
|
Details | ||
| 7/18/2019 | Abbott Labs | ABT | Maintain | Outperform (N/A) |
|
Details | ||
| 6/6/2019 | Abbott Labs | ABT | Maintain | Outperform (N/A) |
|
Details | ||
| 5/30/2019 | Boston Scientific | BSX | Maintain | Outperform (N/A) |
|
Details | ||
| 5/13/2019 | Nevro Corp | NVRO | Maintain | Outperform (N/A) |
|
Details | ||
| 5/9/2019 | Glaukos Corporation | GKOS | Maintain | Market Perform (N/A) |
|
Details | ||
| 5/2/2019 | DexCom | DXCM | Maintain | Outperform (N/A) |
|
Details | ||
| 5/1/2019 | Tandem Diabetes Care | TNDM | Maintain | Outperform (N/A) |
|
Details | ||
| 4/29/2019 | Silk Road Medical | SILK | New Coverage | Outperform (N/A) |
37.80 (27.49) |
-27.28% | Details | |
| 4/25/2019 | Boston Scientific | BSX | Maintain | Outperform (N/A) |
|
Details | ||
| 4/18/2019 | Alcon Inc. | ALC | New Coverage | Market Perform (N/A) |
56.61 (67.35) |
18.97% | Details | |
| 4/17/2019 | Johnson & Johnson | JNJ | Maintain | Outperform (N/A) |
|
Details | ||
| 3/27/2019 | iRhythm Technologies | IRTC | Maintain | Outperform (N/A) |
|
Details | ||
| 3/22/2019 | Edwards Lifesciences | EW | Maintain | Outperform (N/A) |
|
Details | ||
| 3/22/2019 | Endologix | ELGX | Maintain | Market Perform (N/A) |
|
Details | ||
| 3/20/2019 | Nevro Corp | NVRO | Upgrade | Outperform (Market Perform) |
44.40 (5.84) |
-86.85% | Details | |
| 3/13/2019 | Wright Medical | WMGI | Maintain | Outperform (N/A) |
|
Details | ||
| 3/8/2019 | Tandem Diabetes Care | TNDM | New Coverage | Outperform (N/A) |
61.78 (16.91) |
-72.63% | Details | |
| 3/6/2019 | Cooper Companies | COO | Maintain | Outperform (N/A) |
|
Details | ||
| 2/22/2019 | Nevro Corp | NVRO | Downgrade | Market Perform (Outperform) |
47.38 (44.40) |
-6.29% | Details | |
| 2/7/2019 | Boston Scientific | BSX | Maintain | Outperform (N/A) |
|
Details | ||
| 2/1/2019 | Baxter International | BAX | Maintain | Outperform (N/A) |
|
Details | ||
| 2/1/2019 | Edwards Lifesciences | EW | Maintain | Outperform (N/A) |
|
Details | ||
| 12/14/2018 | Johnson & Johnson | JNJ | Maintain | Outperform (N/A) |
|
Details | ||
| 12/10/2018 | ResMed | RMD | Upgrade | Outperform (Market Perform) |
112.35 (192.91) |
71.7% | Details | |
| 11/8/2018 | Glaukos Corporation | GKOS | Maintain | Market Perform (N/A) |
|
Details | ||
| 11/6/2018 | Penumbra | PEN | Maintain | Market Perform (N/A) |
|
Details | ||
| 11/6/2018 | Nevro Corp | NVRO | Maintain | Outperform (N/A) |
|
Details | ||
| 11/1/2018 | Baxter International | BAX | Maintain | Outperform (N/A) |
|
Details | ||
| 10/31/2018 | NuVasive | NUVA | Maintain | Market Perform (N/A) |
|
Details | ||
| 10/26/2018 | ResMed | RMD | Maintain | Market Perform (N/A) |
|
Details | ||
| 9/5/2018 | Glaukos Corporation | GKOS | Maintain | Market Perform (N/A) |
|
Details | ||
| 8/31/2018 | Cooper Companies | COO | Maintain | Outperform (N/A) |
|
Details | ||
| 8/28/2018 | Wright Medical | WMGI | Upgrade | Outperform (Market Perform) |
26.79 (29.98) |
11.91% | Details | |
| 8/13/2018 | Endologix | ELGX | Maintain | Market Perform (N/A) |
|
Details |
